MedTrace Logo

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

NCT05520099 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 416

Last updated 2026-04-29

No results posted yet for this study

Summary

The primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method

Conditions

Interventions

PROCEDURE

Core Needle Biopsy, Forceps Biopsy, Punch Biopsy

Subjects must be clinically able, at investigator discretion, to undergo additional core needle biopsy, forceps biopsy, or punch biopsy passes during their biopsy. These additional biopsies may either be collected from the primary tumor or a metastatic site amenable to additional passes (e.g., liver or lymph nodes) per the clinician.

Sponsors & Collaborators

  • Elephas

    lead INDUSTRY

Principal Investigators

  • Fred Hausheer, MD, FACP · Elephas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-26
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05520099 on ClinicalTrials.gov